Gonadal germ cell tumors continue to be the cause of diverse, diagnostically challenging
issues for the pathologist, and their correct resolution often has major important therapeutic …

Purpose To review contemporary management of malignant ovarian germ cell tumors
(MOGCT). Design The literature on the topic of MOGCT is reviewed, including pathology …

Abstract The Oct-3/4 transcription factor sustains embryonic stem (ES) cell self-renewal and
is a dose-dependent cell fate determinant. In the adult male, its expression is restricted to …

PURPOSE This study was performed to determine the effectiveness of postoperative
adjuvant chemotherapy in patients with surgically resected ovarian germ cell tumors …

The clinical and pathologic features of 254 teratomas from 245 patients are reviewed. All
patients were 21 years of age or younger and were treated at the Children's Hospital …

PURPOSE: To determine whether the 3-year event-free survival (EFS) of children with
completely resected immature teratomas is greater than 85%. PATIENTS AND METHODS …

Since 1984, we have treated 26 patients with malignant ovarian germ cell tumors with a
combination of bleomycin, etoposide (VP-16), and cisplatin (BEP) at The University of Texas …

PURPOSE: Malignant ovarian germ cell tumors (MOGCTS) are rare but curable at all stages
of disease. This review gives an outline of the management of this disease. METHODS: We …

Extragonadal germ cell tumors (GCTs) are relatively uncommon, but represent 1% to 5% of
all GCTs. Their morphology varies widely and includes mature teratoma, immature teratoma …

This group of ovarian neoplasms is composed of a number of histologically different tumor
types and embraces all the neoplasms considered to be ultimately derived from the primitive …